Amanda Finan, Head of IHC R&D Cerba Research, Nithianandan Selliah, Global Head of Flow Cytometry Cerba Research, and Raouf Ben Abdelali, Head of the Hematology and Oncology Division, Cerba Laboratory will guide you through their respective fields of expertise and answer the above questions.
Our experts Goran Marinkovic, PhD, Immunologist, Nele Langenaken, General Manager, Dr. Nithianandan Selliah, PhD, Global Director, Flow Cytometry and Dr. Karthikeyan Devaraju, PhD, Scientist will bring together best practices in genomics, flow cytometry, biomarkers and clinical trial operations.
On November 16, 2021 Cerba Research and Akoya Biosciences held a webinar on how to analyze multiple biomarkers using Immunohistochemistry (IHC). The session was a deep dive in the Tissue Microenvironment (TME) with multiplex IF (Opal™) technology, discovering how to visualize, analyze, and quantify multiple phenotypes in situ.
Discover how expert bioanalytical teams are tackling the complexities of antibody-drug conjugate (ADC) development in our on-demand webinar, “Overcoming Bioanalytical Challenges in Anti-Drug Antibody Detection for ADCs.”
